Journals / Türk Patoloji Dergisi / 2015 / Cilt: 31 - Sayı: 3

Küçük Hücreli Dışı Akciğer Karsinomunda p63, TTF-1 ve Maspin Ekspresyonu - Prognoz ve Ayırıcı Tanı Üzerine Etkileri

Expression of p63, TTF 1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis

Pages
163–174
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Material and Method: p63, TTF-1 and maspin expression and theirrole in the differential diagnosis, overall survival, progression-freesurvival and other clinicopathological characteristics of the patientswere investigated in 80 surgically-resected non-small cell lungcarcinomas.Results: The maximal tumor diameter range was 1.5 11 cm (mean:4.06±1.8 cm).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obj ective: Lung cancer is still the leading cause of cancer mortality.Antiapoptotic genes and protease inhibitors play an important role inthe development of lung cancer.
📊
Key Findings & Data:Material and Method: p63, TTF-1 and maspin expression and theirrole in the differential diagnosis, overall survival, progression-freesurvival and other clinicopathological characteristics of the patientswere investigated in 80 surgically-resected non-small cell lungcarcinomas.Results: The maximal tumor diameter range was 1.5 11 cm (mean:4.06±1.8 cm).
💡
Conclusion & Impact:However, more studies are required toelucidate the significance of maspin.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Obj ective: Lung cancer is still the leading cause of cancer mortality.Antiapoptotic genes and protease inhibitors play an important role inthe development of lung cancer. Material and Method: p63, TTF-1 and maspin expression and theirrole in the differential diagnosis, overall survival, progression-freesurvival and other clinicopathological characteristics of the patientswere investigated in 80 surgically-resected non-small cell lungcarcinomas.Results: The maximal tumor diameter range was 1.5 11 cm (mean:4.06±1.8 cm). Forty-five (56.3%) tumors were adenocarcinoma, 23(28.8%) squamous cell carcinoma, four (5%) large cell carcinoma,six (7.5%) large cell neuroendocrine carcinoma, one (1.2%)sarcomatoid carcinoma while one was (1.2%) both adenocarcinomaand squamous cell carcinoma. The patients with advanced TNmstage and a tumor diameter more than 3 cm had markedly poorsurvival. Immunohistochemically, p63 staining was present in 87.5%of squamous cell carcinomas, 4.3% of adenocarcinomas, 25% of largecell carcinomas, and 16.7% of large cell neuroendocrine carcinomas.Similarly, maspin was positive in 66.7% of squamous cell carcinomasand 17.4% of adenocarcinomas. The TTF 1 staining rate was higherin adenocarcinomas (84.8%). There was no immunoreactivity insquamous cell carcinomas (p0.05)while maspin has a negative prognostic effect in adenocarcinoma(p=0.048). Conclusion: This study suggests that p63 and TTF 1 are reliablemarkers in non-small cell lung carcinoma and can be used indifferential diagnosis. maspin has been identified as a prognosticmarker in adenocarcinoma. However, more studies are required toelucidate the significance of maspin.

Özet

Amaç: Akciğer kanseri, kanser ölümlerinin önde gelennedenlerindendir. Antiapopitotik genler ve proteaz inhibitörleriakciğer kanseri gelişiminde önemli role sahiptir.Gereç ve Yöntem: Seksen opere küçük hücreli dışı akciğer karsinomolgusunda p63, TTF 1 ve maspin ekspresyonunun ayırıcı tanıya olankatkıları, sağkalım ve hastalıksız sağkalım üzerine etkileri ve diğerklinikopatolojik özellikler değerlendirildi.Bulg ular: Ameliyat materyallerinde izlenen tümörlerin çapları1,5 11 cm arasında (ort. 4,06±1,8) olup, 45 (%56,3) adenokarsinom,23 (%28,8) skuamöz hücreli karsinom, dört (%5) büyük hücrelikarsinom, altı (%7,5) büyük hücreli nöroendokrin karsinom, bir(%1,2) sarkomatoid karsinom ve bir (%1,2) adenokarsinom veskuamöz hücreli karsinom birlikteliğinden oluşmakta idi. İleri TNmevreli ve üç cmden daha büyük tümör çapı olan olgular daha kötüprognozlu idi. İmmünohistokimyasal incelemede skuamöz hücrelikarsinomların %87,5i, adenokarsinomların %4,3ü, büyük hücrelikarsinomların %25i ve büyük hücreli nöroendokrin karsinomların%16,7si p63 ile pozitif boyandı. Benzer olarak maspin de skuamözhücreli karsinomlarda %66,7 ve adenokarsinomlarda %27,4 oranındapozitifti. TTF-1 ekspresyonu, adenokarsinomlarda oldukça yüksekoranda idi (%84,8). Skuamöz hücreli karsinomlarda immünreaktiviteizlenmedi (p

🔖

Cite This Article

ÇOK, G., Pervin, E. K., NART, D., VERAL, A., YAMAN, B. (2022). Küçük Hücreli Dışı Akciğer Karsinomunda p63, TTF-1 ve Maspin Ekspresyonu - Prognoz ve Ayırıcı Tanı Üzerine Etkileri. Türk Patoloji Dergisi, Cilt: 31 - Sayı: 3, 163–174. https://ajindex.com/articles/640590

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Olak J, Colson Y. Gender differences in lung cancer: Have we really come a long way, baby? Thorac Cardiovasc Surg. 2004;128:346- 51
  2. William D. Travis, Elisabeth Brambilla, H. Konrad müller- Hermelink, Curtis C. Harris. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Kleihues P, Sobin LH, editors. Lyon: IArC;2004 3. massion PP, Taflan Pm, Jamshedur rahman Sm, Yildiz P, Shyr Y, Edgerton mE, Westfall mD, roberts Jr, Pietenpol JA, Carbone DP, Gonzalez AL. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer res. 2003;63:7113-21
  3. Wang BY, Gil J, Kaufman D, Gan L, Kohtz DS, Burstein DE. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol. 2002;33:921-6
  4. Afify Am, al-Khafaji Bm. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. Acta Cytol. 2002;46:675-8
  5. Di Loreto C, Di Lauro V, Puglisi F, Damante G, Fabbro D, Beltrami CA. Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol. 1997;50:30-2
  6. Smith SL, Watson SG, ratschiller D, Gugger m, Betticher DC, Heighway J. maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions. Oncogene. 2003;22:8677-87
  7. Katakura H, Takenaka K, Nakagawa m, Sonobe m, Adachi m, Ito S, Wada H, Tanaka F. maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). maspin in NSCLC. Lung Cancer. 2006;51:323-8
  8. Nakashima m, Ohike N, Nagasaki K, Adachi m, morohoshi T. Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma. J Cancer res Clin Oncol. 2004;130:475-9
  9. Au NH, Cheang m, Huntsman DG, Yorida E, Coldman A, Elliott Wm, Bebb G, Flint J, English J, Gilks CB, Grimes HL. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: A tissue microarray study of 284 cases and 18 markers. J Pathol. 2004;204:101-9
  10. Berghmans T, mascaux C, martin B, Ninane V, Sculier JP. Prognostic role of thyroid transcription factor-1 in stage III non- small cell lung cancer. Lung Cancer. 2006;52:219-24
  11. Goksel T, Akkoclu A. Pattern of lung cancer in Turkey, 1994- 1998. respiration. 2002;69:207-10
  12. Hirsch Fr, Franklin WA, Gazdar AF, Bunn PA Jr. Early detection of lung cancer